Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy

Abstract

In conclusion, PL or autologous serum could offer an alternative to the use of FCS in MSC expansion for clinical use maintaining the same growing potential, phenotype, immunomodulatory properties, and differentiation potential.